April 20, 2021 Enzychem Lifesciences Selected to Collaborate with NIAID CCRP on the CERF Program Explore further
April 16, 2021 Enzychem Lifesciences Announces Oral Presentation of TLR Signaling Inhibition with Mosedipimod (EC-18) at The International Liver Congress 2021 (EASL) Explore further
April 6, 2021 Enzychem Lifesciences Announces Last Patient Enrolled in Stage 2 of Phase 2 Study of EC-18 in Chemoradiation Induced Oral Mucositis Explore further
March 11, 2021 Enzychem Lifesciences Selected to Participate at the 15th New York Health Forum: Investing in Space – Next Frontier of Healthcare Explore further
March 1, 2021 Enzychem Lifesciences to Present at the 2021 NASH-TAG Conference Highlighting TLR Signaling Inhibition with Mosedipimod (EC-18) Explore further
February 8, 2021 Enzychem Lifesciences Announces Poster Presentation At AACR VirtualAnnual Meeting 2021 Explore further
